Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany

In 2011, intranasally administered live attenuated influenza vaccine (LAIV) was approved in the EU for prophylaxis of seasonal influenza in 2–17-year-old children. Our objective was to estimate the potential epidemiological impact and cost-effectiveness of an LAIV-based extension of the influenza va...

Descripción completa

Detalles Bibliográficos
Autores principales: Damm, Oliver, Eichner, Martin, Rose, Markus Andreas, Knuf, Markus, Wutzler, Peter, Liese, Johannes Günter, Krüger, Hagen, Greiner, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435640/
https://www.ncbi.nlm.nih.gov/pubmed/24859492
http://dx.doi.org/10.1007/s10198-014-0586-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435640/
https://www.ncbi.nlm.nih.gov/pubmed/24859492
http://dx.doi.org/10.1007/s10198-014-0586-4

Ejemplares similares